
The Bipartisan Commission on Biodefense convened at the Atlantic Council to chart the evolving threat landscape of biological toxins. Experts examined how state and non‑state actors could weaponize agents such as ricin, botulinum toxin, and newly engineered proteins. The briefing highlighted gaps in detection infrastructure, limited antitoxin stockpiles, and the accelerating role of synthetic biology. Commissioners concluded that coordinated policy action is essential to mitigate future toxin‑driven attacks.

A former military and State Department adviser argues that US-Turkey ties have been strained for a decade by conflicting Syria policies, and likens the need to resolve that strain to the medical principle of removing the "mechanism of harm." He...

The video features Dr. Brian Fonseca discussing how China’s expanding economic, technological, and security footprint in Latin America and the Caribbean is reshaping U.S. hemispheric strategy. He frames the issue within the latest U.S. National Security Strategy, which labels Beijing...

Speakers at the Atlantic Council event argued that amid a perceived shift away from a US-led rules-based order, Turkey is consolidating its role as a middle power by pursuing strategic autonomy through hedging, expanded defense and energy self-sufficiency, regional mediation,...

The Munich Security Conference centered on the future of the transatlantic partnership, highlighting a noticeable shift in Washington’s tone. After a year of sharp rhetoric, U.S. officials presented a more conciliatory, "charm offensive" aimed at easing tensions with European allies. Analysts...